"A world-wide prospective study of INC on prognosis and biomarkers in GBS"

A world-wide prospective study of INC on prognosis and biomarkers in GBS

Publication success Oct/15/2019

  1. Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomized ISID study, was written by Christine Verboon and members of the IGOS consortium, using the patient data collected in IGOS. The objective of the study was to compare disease course in patients with GBS with a poor prognosis who were treated with one versus two IVIg courses. They showed that outcomes were not better after a second IVIg course. 
  2. Current treatment practice of Guillain-Barré syndrome, another paper written by Christine Verboon and members of the IGOS consortium, using data from the first 1,300 patients included in IGOS. The objective of the study was to define the current treatment practice of GBS around the world.
  3. Diagnosis and management of Guillain–Barré syndrome in ten steps, a paper written by Sonja Leonhard and members of the IGOS-Zika team. The aim of this paper was to write easy-to-use and internationally applicable guidelines for GBS, using a step-by-step approach.

< Back to overview